APPLICATION
NDA017503
TYPE
NDA
ORIGINAL APPROVAL
1974-09-03
LATEST ACTION
1999-09-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
COMBIPRES · ReferenceDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
COMBIPRES · ReferenceDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
COMBIPRES · ReferenceDiscontinued
CHLORTHALIDONE 15MG, CLONIDINE HYDROCHLORIDE 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
Approval history
1999-09-15Manufacturing (CMC) · Supplement 28 · priorityAP
1991-04-08Manufacturing (CMC) · Supplement 27 · priorityAP
1991-02-20Labeling · Supplement 26 · priorityAP
1987-08-07Manufacturing (CMC) · Supplement 25 · priorityAP
1987-03-26Labeling · Supplement 24 · priorityAP
1986-04-10Labeling · Supplement 23 · priorityAP
1985-10-02Labeling · Supplement 22 · priorityAP
1985-02-25Manufacturing (CMC) · Supplement 20 · priorityAP
1984-12-18Manufacturing (CMC) · Supplement 21 · priorityAP
1984-11-19Manufacturing (CMC) · Supplement 19 · priorityAP
1984-08-01Manufacturing (CMC) · Supplement 18 · priorityAP
1984-04-10Labeling · Supplement 17 · priorityAP
1983-03-09Manufacturing (CMC) · Supplement 16 · priorityAP
1981-07-31Manufacturing (CMC) · Supplement 15 · priorityAP
1981-04-09Manufacturing (CMC) · Supplement 14 · priorityAP
1981-02-05Manufacturing (CMC) · Supplement 5 · priorityAP
1981-01-15Manufacturing (CMC) · Supplement 12 · priorityAP
1980-11-28Manufacturing (CMC) · Supplement 13 · priorityAP
1980-11-28Manufacturing (CMC) · Supplement 11 · priorityAP
1980-11-28Manufacturing (CMC) · Supplement 10 · priorityAP
1980-02-26Manufacturing (CMC) · Supplement 9 · priorityAP
1980-02-26Manufacturing (CMC) · Supplement 8 · priorityAP
1979-01-31Manufacturing (CMC) · Supplement 7 · priorityAP
1977-01-17Manufacturing (CMC) · Supplement 3 · priorityAP
1976-12-10Manufacturing (CMC) · Supplement 4 · priorityAP
1976-07-09Manufacturing (CMC) · Supplement 2 · priorityAP
1976-06-08Manufacturing (CMC) · Supplement 1 · priorityAP
1974-09-03Type 1 - New Molecular Entity and Type 4 - New Combination · Original · priorityAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.